ArticleBMC cancer2025
Climbing the ladder of health technology utilization: facilitators and dynamic mechanism of clinicians' contrast-enhanced ultrasound utilization in China.
Article in BMC cancer, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
backgroundPromoting health technology utilization is essential for improving the capability of disease diagnosis and treatment. Nevertheless, the knowledge-product nature of health technology seems to be ignored, and different levels of technology utilization have seldom been investigated. This study took Contrast-enhanced ultrasound (CEUS) as an example to identify different levels of technology utilization and investigate the facilitators of clinicians’ CEUS use in China and the dynamic mechanism for upgrading technology utilization, which would benefit from studying the general pattern of health technology dissemination and utilization.
methodsA structured questionnaire survey with multi-stage random sampling was conducted between February and August 2019. Clinicians who were aware of CEUS and worked at the liver disease-related departments of sampled health institutions in Jiangxi and Fujian provinces were invited to participate in the survey. Multilevel regression analysis was conducted to determine factors influencing different levels of health technology utilization, and structural equation modeling was applied to validate theoretical hypotheses for developing the dynamic mechanism model.
resultsA total of 289 clinicians were included. The average scores for symbolic, conceptual, and instrumental utilization were 2.497 ± 1.190, 1.719 ± 1.536, and 1.668 ± 1.452, respectively. It indicated that clinicians’ CEUS utilization was clustered in the same hospital. Market pressure (β = 0.221, P < 0.01) and organizational support (β = 0.278, P < 0.001) were significantly associated with symbolic utilization; subjective norms(β = 0.154, P < 0.01), organizational support (β = 0.228, P < 0.001), and organizational culture (β=-0.155, P < 0.01) were significantly linked to conceptual utilization; and perceived ease of use (β = 0.085, P < 0.05) was positively relevant to instrumental utilization. Additionally, there was a significant impact of symbolic utilization on conceptual utilization (β = 0.668, P < 0.001), as well as conceptual utilization on instrumental utilization (β = 0.843, P < 0.001).
conclusionsThis study evaluated the key influences on CEUS utilization at three levels, and then constructed a theoretical model of the dynamic mechanisms that drive technology utilization to a higher level. It will fill gaps in knowledge about the dynamics mechanisms of climbing the ladder of technology utilization, and provide practical guidance for promoting the wider utilization of CEUS and other health technologies. Some recommendations for clinicians and managers were also proposed from individual and organizational perspectives.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.